| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/12/2004 | US20040029820 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/12/2004 | US20040029803 Binding to apoptosis cells |
| 02/12/2004 | US20040029801 Antiinflammatory agents; immunosuppressants; inflammatory bowel disease; antiarthritic agents; autoimmune diseases; administering drug and immunosuppressant |
| 02/12/2004 | US20040029782 Antiinflammatory agents; osteoporosis; cardiovascular disorders; coating for prosthetics |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/12/2004 | US20040028815 Combinatorial synthesis |
| 02/12/2004 | US20040028758 Antioxidant composition and method of preparation thereof |
| 02/12/2004 | US20040028734 Muscular disorders; antiproliferative agents; antiinflammatory agents |
| 02/12/2004 | US20040028674 Biological materials and the use thereof for the treatment of disease |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | CA2494305A1 Preptin methods of use |
| 02/12/2004 | CA2494121A1 Modulation of mesenchymal cells via iga-receptors |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2493795A1 Method of preparing platelet rich plasma |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388343A1 Antioxidant composition and method of preparation thereof |
| 02/11/2004 | EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 02/11/2004 | EP1387836A1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 02/11/2004 | EP1387833A1 Protease-inhibitors |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387688A2 Benzazepinone alpha v integrin receptor antagonists |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1387676A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| 02/11/2004 | EP1165491B1 Lta4 hydrolase inhibitors |
| 02/11/2004 | EP1144393B1 Benzoxazole derivatives for use as integrin inhibitors |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474804A 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474700A Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 02/11/2004 | CN1474690A Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1473629A Method for preparing high activity bone defect repairing material |
| 02/11/2004 | CN1473612A Paste for relieving swelling and alleviating pain and its producing method |
| 02/11/2004 | CN1473611A Rheumatism paste and its preparing method |
| 02/11/2004 | CN1473592A External-use medicine for treating rheumatoid arthritis and its preparing method |
| 02/11/2004 | CN1137993C Recombinant adenovirus of bone morphogenetic protein and its method for exciting bone generation |
| 02/11/2004 | CN1137898C Analogs of parathyroid hormone |
| 02/11/2004 | CN1137891C Process for preparing growth hormone cinogenic agent |
| 02/11/2004 | CN1137888C Inhibitor of cysteninyl aspartic acid proteinase |
| 02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/11/2004 | CN1137728C Anti-carious chewing gums, candies, gels, tooth-paste and dentifrices |
| 02/11/2004 | CN1137715C Chinese medicinal preparation for treating erythematosus |
| 02/10/2004 | US6689922 Vitamin D analogues |
| 02/10/2004 | US6689906 Bicyclic amino acids as pharmaceutical agents |
| 02/10/2004 | US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity |
| 02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689785 Epoxysuccinamide derivatives |
| 02/10/2004 | US6689784 Controlling cell apoptosis |
| 02/10/2004 | US6689783 Aryl oxime-piperazines useful as CCR5 antagonists |
| 02/10/2004 | US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689764 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/10/2004 | US6689747 Use of insulin for the treatment of cartilagenous disorders |
| 02/10/2004 | US6689570 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 02/10/2004 | CA2291975C Quaternary ammonium compounds |
| 02/10/2004 | CA2274381C Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin e2 |
| 02/10/2004 | CA2164951C Lipoxin compounds |
| 02/10/2004 | CA2134196C Pharmaceutical preparation and process for its manufacture |
| 02/10/2004 | CA2108903C Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/05/2004 | WO2004011661A1 Novel physiologically active substances |
| 02/05/2004 | WO2004011640A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 02/05/2004 | WO2004011637A2 Modified adamts4 molecules and method of use thereof |
| 02/05/2004 | WO2004011611A2 Taci antibodies and uses thereof |
| 02/05/2004 | WO2004011470A1 Furoisoquinoline derivative and use thereof |
| 02/05/2004 | WO2004011465A1 Kinase inhibitors |
| 02/05/2004 | WO2004011459A1 Novel physiologically active substance |
| 02/05/2004 | WO2004011444A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2004011402A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 02/05/2004 | WO2004010974A2 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | WO2004010973A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | WO2004010972A2 Pellicle-resistant gelatin capsule |
| 02/05/2004 | WO2004010951A2 Method of treating tumors |
| 02/05/2004 | WO2004010945A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | WO2003087818A3 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 02/05/2004 | WO2003084938A3 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases |
| 02/05/2004 | WO2003084560A3 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |